Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease-Reference-Cited by-同舟云学术

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease

Published:2019-02-13 Issue:1 Volume:21 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Cavalli Giulio^ORCID,Tomelleri Alessandro,De Luca Giacomo,Campochiaro Corrado,Dinarello Charles A.,Baldissera Elena,Dagna Lorenzo

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-019-1843-9.pdf

Reference5 articles.

1. Cavalli G, Franchini S, Aiello P, Guglielmi B, Berti A, Campochiaro C, Sabbadini MG, Baldissera E, Dagna L. Efficacy and safety of biological agents in adult-onset Still's disease. Scand J Rheumatol. 2015;44(4):309–14.

2. Junge G, Mason J, Feist E. Adult onset Still’s disease-the evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review). Semin Arthritis Rheum. 2017;47(2):295–302.

3. Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, et al. Response to Interleukin-1 inhibitors in 140 Italian patients with adult-onset Still’s disease: a multicentre retrospective observational study. Front Pharmacol. 2017;8:369.

4. Cavalli G, Dinarello CA. Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology (Oxford). 2015;54(12):2134–44.

5. Pouchot J, Arlet JB. Biological treatment in adult-onset Still’s disease. Best Pract Res Clin Rheumatol. 2012;26(4):477–87.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans;Clinical Immunology;2023-12

2. Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry;Frontiers in Medicine;2022-12-22

3. Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guideline;Zeitschrift für Rheumatologie;2022-12-15

4. DGRh-S2e-Leitlinie;Zeitschrift für Rheumatologie;2022-11-11

5. Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment;International Journal of Molecular Sciences;2022-10-24